Freitag Gregory Gene bought AXGN
June 4, 2024 · Form 4 insider transaction
Freitag Gregory Gene bought 11,904 shares of Axogen, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,904
Price
$0.00
Total value
N/A
InsiderFreitag Gregory Gene
RoleDirector
CompanyAxogen, Inc. (AXGN)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 4, 2024
Filing dateJune 6, 2024
Shares owned after283,498
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock.